期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 21, 期 7, 页码 861-893出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871520620666200721104431
关键词
Apoptosis; anti-proliferative; structural activity relationship; pyrimidine; green chemistry; synthesis; SAR
资金
- RGU: RGU/ADV [RES/GRANTS/059/2016-17 DATED: 30.01.2017]
The rationale of drug design involves strategic use of heterocyclic fragments like pyrimidine to create targeted anti-cancer agents. By studying the structural activity relationship and utilizing eco-friendly synthetic approaches, small molecules with pyrimidine scaffold may offer high potential in cancer therapy.
The rationale behind drug design is the strategic utilization of heterocyclic fragments with specific physicochemical properties to form molecular targeted agents. Among the heterocyclic molecules, pyrimidine has proved to be a privileged pharmacophore for various biological cancer targets. The anti-cancer potential of small molecules with fused and substituted pyrimidines can be enhanced through bioisosteric replacements and altering their ADME parameters. Although several small molecules are used in cancer chemotherapy, oncology therapeutics has various limitations, especially in their routes of administration and their concurrent side effects. Such pernicious effects may be overcome, via selective biological targeting. In this review, the biological targets, to inhibit cancer, have been discussed. The structural activity relationship of fused and substituted pyrimidines was studied. Eco-friendly synthetic approaches for pyrimidine derivatives have also been discussed. This review will give an insight to scientists and researchers of medicinal chemistry discipline to design small molecules having a pyrimidine scaffold with high anti-cancer potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据